Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Sarepta Therapeutics Announces Expanded US FDA Approval of Elevidys to Duchenne Muscular Dystrophy Patients Ages 4 and Above

(BUSINESS WIRE)--Jun. 20, 2024-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced...

FDA Approves Sofdra (sofpironium) Topical Gel for the Treatment of Primary Axillary Hyperhidrosis

Clinical dermatology company, Botanix Pharmaceuticals Ltd. (ASX:BOT, Botanix or the Company), is pleased to announce the US Food and Drug Administration...

FDA Approves Skyrizi (risankizumab-rzaa) for Ulcerative Colitis

AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved Skyrizi® (risankizumab-rzaa) for adults with moderately...

FDA Approves Vigafyde (vigabatrin) as the First and Only Ready-to-Use Vigabatrin Oral Solution

(BUSINESS WIRE) June 17, 2024 --Pyros Pharmaceuticals, Inc. (Pyros or the Company), a leader in the development of enhanced specialty pharmaceuticals for...

FDA Approves Capvaxive (pneumococcal 21-valent conjugate vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults

(BUSINESS WIRE) June 17, 2024 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug...

FDA Approves Yimmugo (immune globulin intravenous, human-dira) to Treat Primary Immunodeficiencies

Barcelona, Spain, June 17, 2024 – Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), one of the world’s leading producers of plasma-derived medicines,...

Common Cholesterol-Lowering Drug Found to Slow Vision Loss in Diabetes Patients

ORLANDO, Fla., June 21, 2024. Today, findings from the Lowering Events in Non-proliferative retinopathy in Scotland (LENS) Trial revealed that fenofibrate,...

FDA Expands Pediatric Indication for Rinvoq

The U.S. Food and Drug Administration has expanded indications for Rinvoq (upadacitinib) to now include pediatric patients (ages 2 years and older) with...

Social Anxiety Tied to Later Risk for Suicidal Ideation, Depression

Baseline social anxiety symptoms are associated with two-year suicidal ideation and depressive symptoms, according to a study published online June 10...

FDA Approves KEYTRUDA + Chemo for Primary Advanced, Recurrent Endometrial Carcinoma

The U.S. Food and Drug Administration has approved Keytruda (pembrolizumab) plus chemotherapy as treatment for adult patients with primary advanced or...

FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine

The U.S. Food and Drug Administration has approved the Capvaxive pneumococcal 21-valent conjugate vaccine for the prevention of invasive pneumococcal disease...

GLP-1 Medicine Mounjaro May Be First Drug to Ease Sleep Apnea

A medication used to manage type 2 diabetes has been found effective in treating sleep apnea.The worldwide clinical trial demonstrates that tirzepatide...

U.S. Gun Injury Rates in 2023 Topped Pre-Pandemic Levels

For the fourth year in a row, rates of gun injuries stayed above levels seen before the pandemic, a new government report shows. Race played a key role...

WHO, Lilly Issue Warnings About Fake Weight-Loss Drugs

Both the World Health Organization and Eli Lilly Co. warned Thursday that consumers should avoid fake versions of weight-loss drugs that are circulating...

Robust Gut Microbiome Can Help You Fight Infections

The bacteria colonizing your bowels play a key part in your risk for infection, new research shows. A study of more than 600 people hospitalized with...

Palatin Announces the Initiation of a Phase 2 Clinical Study of Bremelanotide Co-Administered with a PDE5i for the Treatment of Erectile Dysfunction

CRANBURY, N.J., June 20, 2024. Palatin Technologies, Inc., a biopharmaceutical company developing first-in-class medicines based on molecules that modulate...

Looking for Weight Loss? Go Nuts

Folks dieting to drop pounds should consider eating a fistful of nuts here and there, a new review suggests. People who ate 1.5 to 3 ounces of almonds,...

Read more news...

Recently Added

Recently added consumer and prescribing information: Sofdra, Yimmugo, Iqirvo, Rytelo, mRESVIA, Bkemv, Yesafili, Myhibbin, Rezenopy, Libervant

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Sofdra Sofdra (sofpironium) is a topical anticholinergic indicated for the treatment of primary axillary hyperhidrosis in adults and pediatric...
  • Vigafyde Vigafyde (vigabatrin) is a ready-to-use oral solution formulation of the approved anti-seizure medicine vigabatrin used for the treatment...
  • Capvaxive Capvaxive (pneumococcal 21-valent conjugate vaccine) is a 21-valent pneumococcal conjugate vaccine indicated for active immunization for...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...

More drugs in development